Universal serologic screening for celiac disease among 12-year-olds was more costly and yielded no gains in long-term quality of life in relation with bone health compared with the standard selective screening, a study in the journal Clinical Gastroenterology and Hepatology showed. Researchers also said that universal serological screening can lead to negative outcomes from unneeded endoscopic evaluations of healthy people after a false positive result.

Related Summaries